DT Investment Partners LLC Has $175,000 Holdings in CVS Health Co. (NYSE:CVS)

DT Investment Partners LLC raised its position in shares of CVS Health Co. (NYSE:CVS) by 7.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,777 shares of the pharmacy operator’s stock after buying an additional 202 shares during the period. DT Investment Partners LLC’s holdings in CVS Health were worth $175,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of CVS. Deerfield Management Company L.P. Series C acquired a new position in CVS Health in the second quarter worth $57,584,000. CX Institutional lifted its position in CVS Health by 698.0% during the 3rd quarter. CX Institutional now owns 74,609 shares of the pharmacy operator’s stock worth $4,691,000 after buying an additional 65,259 shares in the last quarter. Susquehanna Fundamental Investments LLC increased its position in CVS Health by 27.9% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator’s stock valued at $39,302,000 after acquiring an additional 145,158 shares in the last quarter. First Hawaiian Bank raised its stake in shares of CVS Health by 30.1% in the second quarter. First Hawaiian Bank now owns 100,302 shares of the pharmacy operator’s stock worth $5,924,000 after acquiring an additional 23,213 shares during the last quarter. Finally, Czech National Bank lifted its position in shares of CVS Health by 7.2% during the third quarter. Czech National Bank now owns 256,430 shares of the pharmacy operator’s stock worth $16,124,000 after purchasing an additional 17,206 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CVS has been the subject of several research analyst reports. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Mizuho decreased their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday. Barclays dropped their price objective on CVS Health from $82.00 to $75.00 and set an “overweight” rating for the company in a report on Wednesday. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $59.00 to $85.00 in a research report on Friday, October 4th. Finally, Truist Financial increased their price objective on shares of CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a report on Friday, October 11th. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $74.58.

CVS Health Price Performance

NYSE CVS opened at $56.11 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25. The business has a 50 day simple moving average of $59.88 and a 200 day simple moving average of $60.17. The stock has a market cap of $70.44 billion, a price-to-earnings ratio of 9.86, a PEG ratio of 0.93 and a beta of 0.54.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period last year, the business posted $2.21 earnings per share. Analysts anticipate that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.74%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.